CytoVeris is developing TumorMAP, an AI-powered cancer imaging technology that can deliver real-time cancer tissue visualization, enabling more precise intraoperative decisions and improving patient outcomes. TumorMAP uses multispectral scans, sent through the body at different wavelengths. They return 16 photos, which are fed into their AI. After only minutes, the computer tells doctors exactly where tumor masses exist in the body. They believe the platform technology could eventually be applied to any tumor mass, but they are currently pursuing approval for bladder cancer. A common treatment for bladder cancer involves scraping the cancerous cells from the inside of the bladder, called a TURBT procedure. Unfortunately doctors often miss cells, meaning many of the 600,000 procedures per year in the US are return surgeries. TumorMAP would allow doctors to check for cancerous masses in real time, eliminating the need for those second surgeries. While they enter Phase III trials for approval on bladder cancer, they are beginning to teach their AI algorithm to recognize tumor masses in the prostate. This will be further bolstered by their robotics partnership with Dr Vipul Patel, one of the most experienced robotics surgeons in the country.